
### [MONDO:0016987](http://purl.obolibrary.org/obo/MONDO_0016987)
**Label:** neuroacanthocytosis

**Subclasses:** [MONDO:0016304](http://purl.obolibrary.org/obo/MONDO_0016304) (classic pantothenate kinase-associated neurodegeneration), [MONDO:0011671](http://purl.obolibrary.org/obo/MONDO_0011671) (Huntington disease-like 2), [MONDO:0008695](http://purl.obolibrary.org/obo/MONDO_0008695) (chorea-acanthocytosis), [MONDO:0016305](http://purl.obolibrary.org/obo/MONDO_0016305) (atypical pantothenate kinase-associated neurodegeneration), [MONDO:0018945](http://purl.obolibrary.org/obo/MONDO_0018945) (McLeod neuroacanthocytosis syndrome), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), 

**Corr. equiv. classes:** [OMIM:606438](http://purl.obolibrary.org/obo/OMIM_606438), [Orphanet:2388](http://www.orpha.net/ORDO/Orphanet_2388), [Orphanet:59306](http://www.orpha.net/ORDO/Orphanet_59306), [Orphanet:216873](http://www.orpha.net/ORDO/Orphanet_216873), [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850), [Orphanet:98934](http://www.orpha.net/ORDO/Orphanet_98934), [OMIM:234200](http://purl.obolibrary.org/obo/OMIM_234200), [Orphanet:216866](http://www.orpha.net/ORDO/Orphanet_216866), [OMIM:200150](http://purl.obolibrary.org/obo/OMIM_200150), 

**Class expressions from DL-Learner:**

- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0004305](http://purl.obolibrary.org/obo/HP_0004305) (Involuntary movements) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0004305](http://purl.obolibrary.org/obo/HP_0004305) (Involuntary movements) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001927](http://purl.obolibrary.org/obo/HP_0001927) (Acanthocytosis) and [HP:0031466](http://purl.obolibrary.org/obo/HP_0031466) (Impairment in personality functioning) 59.97%


